Astellas Pharma | 4503 - Sales Revenues

Stock Price
2,600.50
Daily Change
-57.00 -2.14%
Monthly
8.38%
Yearly
89.06%
Q2 Forecast
2,495.20

Astellas Pharma reported JPY571.21B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Astellas Pharma JPY 571.21B 46.89B Dec/2025
Chugai Pharma JPY 346.3B 13.12B Dec/2025
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Eisai JPY 219.94B 22.58B Dec/2025
Kyowa Hakko Kirin JPY 147.38B 28.58B Dec/2025
M3 JPY 93.51B 8.82B Dec/2025
Otsuka Holdings JPY 650.15B 12.17B Dec/2025
Shionogi JPY 147.72B 34.52B Dec/2025
Sumitomo Dainippon JPY 120.62B 1.5B Dec/2025
Takeda JPY 1.19T 80B Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025